Plant Extracts Inhibiting Herpes Simplex Virus Replication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for herpes simplex virus (HSV) infections, such as Acyclovir and docosanol, have limitations, necessitating the exploration of alternative antiviral agents, particularly from natural sources.
Innovation Solution
The use of plant extracts from species like Achillea millefolium, Cornus species, Trillium erectum, Plantago major, and Trifolium repens, obtained through methods like decoction, reflux, or infusion, which exhibit antiviral activity against HSV-1, including direct inhibition of the virus and reduction of viral replication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional treatments like Acyclovir and docosanol are used, then HSV infections can be treated, but treatment limitations and lack of alternative options persist
Solution Approach 1:
The patent changes the chemical parameter space by introducing plant-derived compounds with different molecular structures and mechanisms of action compared to conventional synthetic antivirals. This diversifies treatment options while providing alternative pathways for viral inhibition through natural product chemistry
Solution Approach 2:
The patent employs composite extraction methods combining multiple solvents (water, ethanol, methanol) to isolate complex mixtures of phytochemicals from plant materials. This composite approach captures synergistic effects of multiple compounds working together against HSV
2Reliability
If plant extracts are used to inhibit HSV-1, then antiviral activity is achieved, but extraction process complexity increases
Solution Approach 1:
The patent segments the extraction process into distinct sequential steps: initial maceration, filtration, concentration, and optional purification. This segmentation allows each step to be optimized independently while maintaining overall process manageability and scalability
Solution Approach 2:
The patent uses solvent systems as intermediaries to transfer active compounds from plant material to solution phase. The choice of solvent (water, ethanol, methanol) acts as a mediator that facilitates selective extraction of different compound classes while enabling subsequent purification steps
3Adaptability or versatility
If multiple plant species are tested, then comprehensive antiviral screening is achieved, but time and resource consumption increase
Solution Approach 1:
The patent performs preliminary extraction and concentration of plant materials before conducting antiviral assays. This preliminary preparation standardizes the test samples and allows parallel processing of multiple plant species, reducing overall screening time while maintaining comprehensive coverage
Solution Approach 2:
The patent screens a diverse panel of plant species exceeding the minimum necessary for statistical significance. This excessive action ensures comprehensive identification of active compounds and mechanisms, providing a robust foundation for selecting the most promising candidates for further development
Data Source
AI summary
The present invention provides a method of using a plant extract or active fraction thereof for inhibiting an herpes simplex virus (HSV) infection, wherein the plant is a: Cornus species; Achillea species; Trifolium species; Trillium species; and/or Plantago species. The present invention also provides plant extracts, active fractions, and compositions kits comprising same.